
Genotic is a pioneering company at the intersection of AI and antibody design, offering a library of over 1,200 AI-designed antibodies. Their innovative approach allows for rapid production of custom antibodies within weeks, utilizing computational techniques to ensure ethical, animal-free design. With a commitment to quality and a focus on scientific advancement, Genotic aims to support researchers in unexplored domains, making significant strides in life science research and combating diseases.

Genotic is a pioneering company at the intersection of AI and antibody design, offering a library of over 1,200 AI-designed antibodies. Their innovative approach allows for rapid production of custom antibodies within weeks, utilizing computational techniques to ensure ethical, animal-free design. With a commitment to quality and a focus on scientific advancement, Genotic aims to support researchers in unexplored domains, making significant strides in life science research and combating diseases.
Core offering: AI-driven design and production of antibodies, proteins, enzymes; library of 1,200+ AI-designed antibodies
Speed claim: Custom antibody production in ~20 days / weeks
Founded: 2021
Industry: Biotechnology
Known investor: Infoshare (grant, May 2023)
Antibody and protein design for research and therapeutic discovery using AI and computational methods.
2021
Biotechnology
20000
Dealroom lists a May 2023 grant from Infoshare (~$20k). Crunchbase lists grant-type funding and Infoshare as lead.
“Infoshare listed as a grantor/investor in public records (May 2023)”